Navigation Links
MedThink Communications Retained by NanoBio Corporation
Date:9/4/2007

RALEIGH, N.C., Sept. 4 /PRNewswire/ -- MedThink Communications, an innovator in health care communications and public relations, has been retained by NanoBio Corporation to promote its novel technology that uses nano-sized particles to eradicate skin infections, without harming normal tissue.

MedThink will implement a scientifically based communications program that includes public relations, advocacy development and medical communications in order to advance NanoBio's lead products, two topical agents (NB-001 and NB-002) that safely treat cold sores and toenail fungus.

"The depth of our scientific expertise allows us to transform highly technical information into readily understandable messages that resonate with a company's key audiences," said Scott Goudy, partner at MedThink. "Our scientific staff works in tandem with the promotional and public relations teams to build a comprehensive, integrated communications program."

NanoBio's scientific platform is in various stages of testing for skin infections, shingles, eye infections, vaginitis, genital herpes, and mucosal vaccines against influenza and hepatitis B. The mucosal vaccines, delivered nasally, will carry antigens that serve to alert and rouse the immune system into action against each respective infection. In the future, NanoBio plans to apply its technology to other mucosal vaccines that may include tuberculosis, small pox, anthrax and other viral and bacterial diseases.

ABOUT MEDTHINK COMMUNICATIONS

MedThink Communications is an award-winning, full-service medical agency whose communication services capture the essence of your brand and transform it into compelling messages that inspire your target audiences. Our innovative approach to advertising, medical communications, public relations, media planning and placement, sales training and marketing consulting serves as the perfect complement to strengthen our health care partners' competitive edge.

SOURCE MedThink Communications
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Physician and Patient relationship strained due to non-verbal communications
2. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ll/ -- PLC Systems Inc.,(AMEX: PLC ), a company f...device-based technologies, announced today that it...oPCR, the annual meeting of the European,Associati...APCI), May,12-16, 2008, in Barcelona, Spain. More ...ted to attend this event., RenalGuard(TM) is base...
(Date:5/12/2008)...s could bring screening test or treatment , ...alled COMT, already known for its role in schizoph...ous obstetric complication known as preeclampsia, ... was done in mice, the researchers envision a time...tify women at risk of preeclampsia -- and even as ...
(Date:5/12/2008)...Call/ -- Cepheid (Nasdaq:,CPHD) today announced it...er, Inc., one of the largest U.S. Group Purchasing...pating hospitals and 42,000 other,healthcare sites...also,signed a preferred vendor agreement with the ...ollaboration of 53 acute care hospitals that utili...
(Date:5/12/2008)...wire/ -- The American,Veterinary Medical Associati... dehorning of cattle to provide veterinarians with...with these procedures. The revised policy,approve...ioners use any,particular method of pain managemen...dations for consideration by practitioners when th...
Breaking Medicine News(10 mins):Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 2Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 3Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 4Health News:Gene May Be Key to Pregnancy Complication 2Health News:Gene May Be Key to Pregnancy Complication 3Health News:Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations 2Health News:Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations 3Health News:Cepheid Signs Group Purchasing Contract With Premier Healthcare Alliance, One of the Largest U.S. Group Purchasing Organizations 4Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2
...s of last year hover around 2 million people, acco...rld Health Organization has suggested an intellige...ica. The WHO has advised that the influence of T...althcare in Africa could be used to give an impetu...
...n overdose of chemotherapy drugs. The Alberta Canc...r. Tony Fields told a news conference on Thursday,...e incident. She died from internal bleeding and mu... our worst nightmares," said Fields, the cancer bo...
...or asthmatic people to control their symptoms will... like Martin Comerford, a hurler from Kilkenny, fo...rom Kerry and referee Brian Gavin have not let the...pact on their lives. Asthma Control Month is bein...
...ve found that a glass of orange juice every day co...ny other citrus juices like lemonade. // The study...n the October. 26 issue of the Clinical Journal of...ndicates though many people are of the assumption ...
Other Medicine News:Health News:Overdose of Chemotherapy Drug kills a woman 2Health News:A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay 2
(Date:5/8/2008)...ewswire-FirstCall/ -- Siemens Healthcare and,Labor...R)) today announced,that they have entered a non-e... to co-develop new clinical diagnostic tests in th...me, oncology and diabetes. Under the,agreement, in...ts that,could make the biggest impact to patient c...
(Date:5/8/2008)...Focus on Use of Pro-Healing Stent with AMI Pati...et Therapy, HONG KONG, May 8 /- Twel...ot study and the real-world registry use of OrbusN...first pro-healing stent, will be,presented next we...ain., The symposium, titled "Clinical Impact of t...
(Date:5/8/2008)...FirstCall/ -- Go Healthy (Pink Sheets: GOHE),annou...h Cholesterade (R),in three medical settings with ... in 6 centers around the country. Dr. William Brya...t Hospital in the Texas Medical Center,will coordi...e Team,Physician for the Houston Astros and the fo...
(Date:5/7/2008)...re-FirstCall/ -- Shire plc (LSE: SHP,Nasdaq: SHPG..., today,announced findings from a new data analysi...ces with DAYTRANA(TM) (methylphenidate transdermal... with Attention Deficit,Hyperactivity Disorder (AD...t DAYTRANA has an established safety profile and e...
Breaking Medicine Technology:Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2Go Healthy Initiates Additional Clinical Tests on Cholesterade 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Workplace Survival 3A Memoir Tells of Woman Who Developed Lung Disease After Exposure to Dangerous Toxins 13627 1Workplace Survival 3A Memoir Tells of Woman Who Developed Lung Disease After Exposure to Dangerous Toxins 13627 2ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic M40403 in Oral Mucositis of Cancer 3751 1ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic M40403 in Oral Mucositis of Cancer 3751 2ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic M40403 in Oral Mucositis of Cancer 3751 3iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 1iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 2iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 3iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 4iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 5iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 6iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 7iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 8iCAD Reports Fourth Quarter and Full Year 2007 Financial Results 13623 9NIOXIN 28R 29 Delivers the Future to Scalp and Hair Care Introduces the First Genetic Test to Determine the Likelihood of Hair Loss 3749 1NIOXIN 28R 29 Delivers the Future to Scalp and Hair Care Introduces the First Genetic Test to Determine the Likelihood of Hair Loss 3749 2NIOXIN 28R 29 Delivers the Future to Scalp and Hair Care Introduces the First Genetic Test to Determine the Likelihood of Hair Loss 3749 3
... Treatment Benefits Were Maintained for at Least 2...nal of Urology, LONDON, May 15, 2007 /PRNewswire/ ...ege London School of Medicine have,announced the r...acebo-controlled study evaluating botulinum toxin ...thic detrusor overactivity (IDO),in patients with ...
... RALEIGH, N.C.--(BUSINESS WIRE)--May 17, 2007 - Sa...unced that results of,18 investigator-initiated tr...sented at Digestive Disease Week(R) 2007, which wi... is considered the,largest and most prestigious me...year it attracts more than 16,000 physicians,rese...
Other Medicine Technology:First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 2First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 3First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
The Portex® ULTRAperc® Percutaneous Dilation Tracheostomy Kits allow the percutaneous insertion of a tracheostomy tube using the widely accepted Seldinger technique by means of a single-stage
Self-contained kits provide convenience and cost control. , ,Our full range of tracheostomy care trays offer a variety of wound dressing components for the effective care and management of the trach
Disposable tracheostomy care tray.
Disposable tracheostomy care tray.
Medicine Products: